{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:43:09Z","timestamp":1774413789236,"version":"3.50.1"},"reference-count":129,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N93019D00031"],"award-info":[{"award-number":["75N93019D00031"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["303442\/2018-2"],"award-info":[{"award-number":["303442\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>The Zika virus (ZIKV) was first isolated from a rhesus macaque in the Zika forest of Uganda in 1947. Isolated cases were reported until 2007, when the first major outbreaks of Zika infection were reported from the Island of Yap in Micronesia and from French Polynesia in 2013. In 2015, ZIKV started to circulate in Latin America, and in 2016, ZIKV was considered by WHO to be a Public Health Emergency of International Concern due to cases of Congenital Zika Syndrome (CZS), a ZIKV-associated complication never observed before. After a peak of cases in 2016, the infection incidence dropped dramatically but still causes concern because of the associated microcephaly cases, especially in regions where the dengue virus (DENV) is endemic and co-circulates with ZIKV. A vaccine could be an important tool to mitigate CZS in endemic countries. However, the immunological relationship between ZIKV and other flaviviruses, especially DENV, and the low numbers of ZIKV infections are potential challenges for developing and testing a vaccine against ZIKV. Here, we discuss ZIKV vaccine development with the perspective of the immunological concerns implicated by DENV-ZIKV cross-reactivity and the use of a controlled human infection model (CHIM) as a tool to accelerate vaccine development.<\/jats:p>","DOI":"10.3390\/pathogens11030294","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T20:48:33Z","timestamp":1645994913000},"page":"294","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5695-8256","authenticated-orcid":false,"given":"Helton C.","family":"Santiago","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 30270-901, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-3275","authenticated-orcid":false,"given":"Tertuliano A.","family":"Pereira-Neto","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 30270-901, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela H.","family":"Gon\u00e7alves-Pereira","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 30270-901, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C. B.","family":"Terzian","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Immunology, Rene Rachou Institute, Fiocruz, Belo Horizonte 30190-002, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna P.","family":"Durbin","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41564-019-0376-y","article-title":"Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus","volume":"4","author":"Kraemer","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Desgraupes, S., Hubert, M., Gessain, A., Ceccaldi, P.E., and Vidy, A. (2021). Mother-to-child transmission of Arboviruses during breastfeeding: From epidemiology to cellular mechanisms. Viruses, 13.","DOI":"10.3390\/v13071312"},{"key":"ref_4","unstructured":"Gimenez-Richarte, A., de Salazar, M.O., Arbona, C., Gimenez-Richarte, M.P., Collado, M., Fernandez, P.L., Quiles, F., Clavijo, C., Marco, P., and Ramos-Rincon, J.M. (Blood Transfus., 2021). Prevalence of chikungunya, dengue and Zika viruses in blood donors: A systematic literature review and meta-analysis, Blood Transfus., online ahead of print."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11538-021-00945-w","article-title":"A Zika endemic model for the contribution of multiple transmission routes","volume":"83","author":"Yuan","year":"2021","journal-title":"Bull. Math. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3201\/eid1509.090442","article-title":"Zika virus outside Africa","volume":"15","author":"Hayes","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_8","first-page":"1085","article-title":"Zika virus, French polynesia, South pacific, 2013","volume":"20","author":"Roche","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","unstructured":"PAHO\/WHO, PAHO (2021, November 27). Timeline of Emergence of Zika Virus in the Americas. Available online: https:\/\/www3.paho.org\/hq\/index.php?option=com_content&view=article&id=11959:timeline-of-emergence-of-zika-virus-in-the-americas&Itemid=41711&lang=en."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1126\/science.aaf5036","article-title":"Zika virus in the Americas: Early epidemiological and genetic findings","volume":"352","author":"Faria","year":"2016","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.meegid.2016.03.030","article-title":"Zika virus complete genome from Salvador, Bahia, Brazil","volume":"41","author":"Giovanetti","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15585\/mmwr.mm6503e2","article-title":"Possible association between Zika virus infection and microcephaly\u2014Brazil, 2015","volume":"65","author":"Ribeiro","year":"2016","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_13","unstructured":"PAHO (2021, December 20). Epidemiological Alert: Neurological Syndrome, Congenital Malformations, and Zika Virus Infection. Implications for Public Health in the America. Available online: https:\/\/iris.paho.org\/handle\/10665.2\/50697?show=full."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/uog.15831","article-title":"Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: Tip of the iceberg?","volume":"47","author":"Malinger","year":"2016","journal-title":"Ultrasound Obstet. Gynecol. Off. J. Int. Soc. Ultrasound Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","article-title":"Zika Virus infection in pregnant women in Rio de Janeiro","volume":"375","author":"Brasil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1473-3099(16)00095-5","article-title":"Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: A case study","volume":"16","author":"Calvet","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e20190883","DOI":"10.1590\/0001-3765202020190883","article-title":"Immunological memory to Zika virus in a University Community in Colombia, South America","volume":"92","author":"Cardenas","year":"2020","journal-title":"Acad. Bras. Cienc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e01390-17","DOI":"10.1128\/mBio.01390-17","article-title":"High Zika virus seroprevalence in Salvador, Northeastern Brazil limits the potential for further outbreaks","volume":"8","author":"Netto","year":"2017","journal-title":"mBio"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Barreto, F.K.A., Alencar, C.H., Araujo, F.M.C., Oliveira, R., Cavalcante, J.W., Lemos, D.R.Q., Farias, L., Boriz, I.L.F., Medeiros, L.Q., and Melo, M.N.P. (2020). Seroprevalence, spatial dispersion and factors associated with flavivirus and chikungunha infection in a risk area: A population-based seroprevalence study in Brazil. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05611-5"},{"key":"ref_20","unstructured":"WHO (2021, December 20). Zika Epidemiology Update. Available online: https:\/\/www.who.int\/emergencies\/diseases\/zika\/zika-epidemiology-update-july-2019.pdf?ua=1."},{"key":"ref_21","unstructured":"PAHO\/WHO (2021, December 20). Cases of Zika Virus Disease by Country or Territory. Weekly Report, Available online: https:\/\/www3.paho.org\/data\/index.php\/en\/?option=com_content&view=article&id=524:zika-weekly-en&Itemid=352."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Jacques, I., Katz, L., Sena, M.A., Guimaraes, A.B.G., Silva, Y.L., Albuquerque, G.D.M., Pereira, R.O., de Albuquerque, C., Silva, M.A.L., and Oliveira, P.A.S. (2021). High Incidence of Zika or Chikungunya Infection among pregnant women hospitalized due to obstetrical complications in Northeastern Brazil-Implications for laboratory screening in Arbovirus endemic area. Viruses, 13.","DOI":"10.3390\/v13050744"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1602113","article-title":"Zika virus","volume":"374","author":"Petersen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_24","first-page":"O595","article-title":"Rapid spread of emerging Zika virus in the Pacific area","volume":"20","author":"Musso","year":"2014","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/S0140-6736(16)30844-3","article-title":"Association between Guillain-Barre syndrome and Zika virus infection","volume":"387","author":"Bautista","year":"2016","journal-title":"Lancet"},{"key":"ref_26","first-page":"20720","article-title":"Zika virus infection complicated by Guillain-Barre syndrome\u2014case report, French Polynesia, December 2013","volume":"19","author":"Oehler","year":"2014","journal-title":"Euro Surveill. Eur. Commun. Dis. Bull."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Mier, Y.T.-R.L., Delorey, M.J., Sejvar, J.J., and Johansson, M.A. (2018). Guillain-Barre syndrome risk among individuals infected with Zika virus: A multi-country assessment. BMC Med., 16.","DOI":"10.1186\/s12916-018-1052-4"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jamaneurol.2018.1058","article-title":"Clinical features of Guillain-Barre Syndrome with vs without Zika virus infection, Puerto Rico, 2016","volume":"75","author":"Dirlikov","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.15585\/mmwr.mm6509e2","article-title":"Increase in Reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy-Brazil, 2015","volume":"65","author":"Henriques","year":"2016","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Freitas, D.A., Souza-Santos, R., Carvalho, L.M.A., Barros, W.B., Neves, L.M., Brasil, P., and Wakimoto, M.D. (2020). Congenital Zika syndrome: A systematic review. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0242367"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6106582","DOI":"10.1155\/2018\/6106582","article-title":"Toll-Like Receptors and RIG-I-Like Receptors play important roles in resisting Flavivirus","volume":"2018","author":"Guo","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika virus infection in human skin cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/eji.201847483","article-title":"Infection with a Brazilian isolate of Zika virus generates RIG-I stimulatory RNA and the viral NS5 protein blocks type I IFN induction and signaling","volume":"48","author":"Hertzog","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.celrep.2018.06.047","article-title":"RIG-I Recognizes the 5\u2032 region of dengue and Zika virus genomes","volume":"24","author":"Chazal","year":"2018","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Schilling, M., Bridgeman, A., Gray, N., Hertzog, J., Hublitz, P., Kohl, A., and Rehwinkel, J. (2020). RIG-I plays a dominant role in the induction of transcriptional changes in Zika virus-infected cells, which protect from virus-induced cell death. Cells, 9.","DOI":"10.3390\/cells9061476"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","article-title":"A Mouse Model of Zika virus pathogenesis","volume":"19","author":"Lazear","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13578-019-0308-9","article-title":"Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains","volume":"9","author":"Hu","year":"2019","journal-title":"Cell Biosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.coviro.2015.04.004","article-title":"How RIG-I like receptors activate MAVS","volume":"12","author":"Wu","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/celldisc.2017.6","article-title":"Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro","volume":"3","author":"Wu","year":"2017","journal-title":"Cell Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","article-title":"Zika Virus Targets Human STAT2 to inhibit type I interferon signaling","volume":"19","author":"Grant","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.15252\/embr.201642627","article-title":"Zika virus inhibits type-I interferon production and downstream signaling","volume":"17","author":"Kumar","year":"2016","journal-title":"EMBO Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.chom.2010.10.007","article-title":"Mouse STAT2 restricts early dengue virus replication","volume":"8","author":"Ashour","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Perry, S.T., Buck, M.D., Lada, S.M., Schindler, C., and Shresta, S. (2011). STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1001297"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1073\/pnas.1607931113","article-title":"Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus","volume":"113","author":"Priyamvada","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.virol.2010.12.020","article-title":"Antibody-mediated neutralization of flaviviruses: A reductionist view","volume":"411","author":"Dowd","year":"2011","journal-title":"Virology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cell.2015.07.005","article-title":"Molecular insight into Dengue Virus pathogenesis and its implications for disease control","volume":"162","author":"Diamond","year":"2015","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/microbiolspec.AID-0022-2014","article-title":"Dengue Antibody-dependent enhancement: Knowns and unknowns","volume":"2","author":"Halstead","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody-dependent enhancement of microbial infection in macrophages: Disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"28768","DOI":"10.1038\/srep28768","article-title":"How antibodies alter the cell entry pathway of dengue virus particles in macrophages","volume":"6","author":"Hoornweg","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imm.13185","article-title":"T-cells producing multiple combinations of IFNgamma, TNF and IL10 are associated with mild forms of dengue infection","volume":"160","author":"Figueiredo","year":"2020","journal-title":"Immunology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/infdis\/jiab312","article-title":"Type 1 Innate Lymphoid Cell and Natural Killer Cells Are Sources of Interferon-gamma and Other Inflammatory Cytokines Associated With Distinct Clinical Presentation in Early Dengue Infection","volume":"225","author":"Santos","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_53","first-page":"781","article-title":"Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection","volume":"215","author":"Castanha","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1099\/vir.0.82537-0","article-title":"Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells","volume":"88","author":"Chareonsirisuthigul","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.it.2016.08.006","article-title":"Dengue antibody and Zika: Friend or foe?","volume":"37","author":"Durbin","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.abb6143","article-title":"Zika virus infection enhances future risk of severe dengue disease","volume":"369","author":"Katzelnick","year":"2020","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Elong Ngono, A., Young, M.P., Bunz, M., Xu, Z., Hattakam, S., Vizcarra, E., Regla-Nava, J.A., Tang, W.W., Yamabhai, M., and Wen, J. (2019). CD4+ T cells promote humoral immunity and viral control during Zika virus infection. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007821"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","article-title":"Mapping and role of the CD8+ T cell response during primary Zika virus infection in mice","volume":"21","author":"Vizcarra","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3389\/fimmu.2019.01678","article-title":"Identification of protective CD8 T Cell responses in a mouse model of Zika virus infection","volume":"10","author":"Hassert","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/s41467-018-05458-0","article-title":"Cross-reactive Dengue virus-specific CD8(+) T cells protect against Zika virus during pregnancy","volume":"9","author":"Viramontes","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_62","first-page":"e170542","article-title":"Analysis of the immunological biomarker profile during acute Zika virus infection reveals the overexpression of CXCL10, a chemokine linked to neuronal damage","volume":"113","author":"Naveca","year":"2018","journal-title":"Mem. Do Inst. Oswaldo Cruz"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Hassert, M., Wolf, K.J., Schwetye, K.E., DiPaolo, R.J., Brien, J.D., and Pinto, A.K. (2018). CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007237"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/JLB.4MA0520-708R","article-title":"Multifunctional T cell response in convalescent patients two years after ZIKV infection","volume":"108","author":"Ramos","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/infdis\/jir012","article-title":"Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection","volume":"203","author":"Hatch","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.4049\/jimmunol.1202234","article-title":"Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response","volume":"190","author":"Blom","year":"2013","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1567-1348(03)00004-2","article-title":"The origin, emergence and evolutionary genetics of dengue virus","volume":"3","author":"Holmes","year":"2003","journal-title":"Infect. Genet. Evol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Ahmed, S.F., Quadeer, A.A., Barton, J.P., and McKay, M.R. (2020). Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008676"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e52384","DOI":"10.7554\/eLife.52384","article-title":"Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics","volume":"8","author":"Durham","year":"2019","journal-title":"eLife"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Hu, D., Zhu, Z., Li, S., Deng, Y., Wu, Y., Zhang, N., Puri, V., Wang, C., Zou, P., and Lei, C. (2019). A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007836"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e00036-17","DOI":"10.1128\/CVI.00036-17","article-title":"Antibody responses to Zika virus infections in environments of Flavivirus endemicity","volume":"24","author":"Keasey","year":"2017","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Delgado, F.G., Torres, K.I., Castellanos, J.E., Romero-Sanchez, C., Simon-Loriere, E., Sakuntabhai, A., and Roth, C. (2018). Improved immune responses against Zika virus after sequential dengue and Zika virus infection in humans. Viruses, 10.","DOI":"10.20944\/preprints201808.0030.v1"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e01469-17","DOI":"10.1128\/JVI.01469-17","article-title":"Prior dengue virus exposure shapes T cell immunity to Zika virus in humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e00755-18","DOI":"10.1128\/mBio.00755-18","article-title":"T cell responses to nonstructural protein 3 distinguish infections by dengue and Zika viruses","volume":"9","author":"Herrera","year":"2018","journal-title":"mBio"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e01992-17","DOI":"10.1128\/JVI.01992-17","article-title":"Sustained specific and cross-reactive T cell responses to Zika and dengue virus NS3 in West Africa","volume":"92","author":"Herrera","year":"2018","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41598-017-18781-1","article-title":"T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses","volume":"8","author":"Reynolds","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune response to dengue and Zika","volume":"36","author":"Ngono","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s41467-019-08845-3","article-title":"Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika","volume":"10","author":"Andrade","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/282509a0","article-title":"Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines","volume":"282","author":"Peiris","year":"1979","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Li, M., Zhao, L., Zhang, C., Wang, X., Hong, W., Sun, J., Liu, R., Yu, L., Wang, J., and Zhang, F. (2018). Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200478"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1038\/cti.2016.72","article-title":"Dengue virus antibodies enhance Zika virus infection","volume":"5","author":"Paul","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"eaav3208","DOI":"10.1126\/sciadv.aav3208","article-title":"Maternal immunity and antibodies to dengue virus promote infection and Zika virus-induced microcephaly in fetuses","volume":"5","author":"Rathore","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_87","first-page":"7614","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization","volume":"536","author":"Dejnirattisai","year":"2016","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e92428","DOI":"10.1172\/jci.insight.92428","article-title":"Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections","volume":"2","author":"Kam","year":"2017","journal-title":"JCI Insight"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.aav6618","article-title":"Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region","volume":"363","author":"Costa","year":"2019","journal-title":"Science"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3855\/jidc.8575","article-title":"Zika virus infection, associated microcephaly, and low yellow fever vaccination coverage in Brazil: Is there any causal link?","volume":"10","author":"Tauil","year":"2016","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Vicente Santos, A.C., Guedes-da-Silva, F.H., Dumard, C.H., Ferreira, V.N.S., da Costa, I.P.S., Machado, R.A., Barros-Aragao, F.G.Q., Neris, R.L.S., Dos-Santos, J.S., and Assuncao-Miranda, I. (2021). Yellow fever vaccine protects mice against Zika virus infection. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009907"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/joim.12638","article-title":"Prospects for induction of CD8 T cell-mediated immunity to Zika virus infection by yellow fever virus vaccination","volume":"282","author":"Blom","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"15674","DOI":"10.1038\/ncomms15674","article-title":"Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus","volume":"8","author":"Pantoja","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"McCracken, M.K., Gromowski, G.D., Friberg, H.L., Lin, X., Abbink, P., De La Barrera, R., Eckles, K.H., Garver, L.S., Boyd, M., and Jetton, D. (2017). Impact of prior Flavivirus immunity on Zika virus infection in rhesus macaques. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006487"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/cid\/cix558","article-title":"Viral load and cytokine response profile does not support antibody-dependent enhancement in dengue-primed zika virus\u2013infected patients","volume":"65","author":"Terzian","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_97","first-page":"351","article-title":"Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and dengue-exposed individuals","volume":"215","author":"Henein","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.4161\/21645515.2014.972131","article-title":"Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naive adults in Mexico","volume":"10","author":"Dayan","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/infdis\/jix314","article-title":"Replication and excretion of the live attenuated tetravalent dengue vaccine CYD-TDV in a Flavivirus-naive adult population: Assessment of vaccine viremia and virus shedding","volume":"216","author":"Torresi","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.4161\/hv.25562","article-title":"Persistence of Th1\/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore","volume":"9","author":"Harenberg","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","article-title":"Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates","volume":"78","author":"Guirakhoo","year":"2004","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/infdis\/jix609","article-title":"Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America","volume":"217","author":"Moodie","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: Hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","article-title":"Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects","volume":"26","author":"Guy","year":"2008","journal-title":"Vaccine"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e133653","DOI":"10.1172\/jci.insight.133653","article-title":"Reciprocal immune enhancement of dengue and Zika virus infection in human skin","volume":"5","author":"Castanha","year":"2020","journal-title":"JCI Insight"},{"key":"ref_111","first-page":"49","article-title":"Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids","volume":"49","author":"Fagbami","year":"1987","journal-title":"Cytobios"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S1473-3099(20)30768-4","article-title":"Zika vaccines: Can we solve one problem without creating another one?","volume":"21","author":"Castanha","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0974-777X.77298","article-title":"Combination vaccines","volume":"3","author":"Skibinski","year":"2011","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41467-021-21384-0","article-title":"A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans","volume":"12","author":"Nivarthi","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jiv289","article-title":"Human CD8+ T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targets","volume":"212","author":"Weiskopf","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Castanha, P.M.S., Souza, W.V., Braga, C., Araujo, T.V.B., Ximenes, R.A.A., Albuquerque, M., Montarroyos, U.R., Miranda-Filho, D.B., Cordeiro, M.T., and Dhalia, R. (2019). Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007246"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Ximenes, R.A.A., Miranda-Filho, D.B., Montarroyos, U.R., Martelli, C.M.T., Araujo, T.V.B., Brickley, E., Albuquerque, M., Souza, W.V., Ventura, L.O., and Ventura, C.V. (2021). Zika-related adverse outcomes in a cohort of pregnant women with rash in Pernambuco, Brazil. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009216"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Castanha, P.M.S., and Marques, E.T.A. (2020). A glimmer of hope: Recent updates and future challenges in zika vaccine development. Viruses, 12.","DOI":"10.3390\/v12121371"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1126\/science.361.6407.1055","article-title":"As massive Zika vaccine trial struggles, researchers revive plan to intentionally infect humans","volume":"361","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/bioe.12802","article-title":"Ethical issues surrounding controlled human infection challenge studies in endemic low-and middle-income countries","volume":"34","author":"Jamrozik","year":"2020","journal-title":"Bioethics"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"70","DOI":"10.12688\/wellcomeopenres.12256.1","article-title":"A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, Malawi","volume":"2","author":"Gordon","year":"2017","journal-title":"Wellcome Open Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.vaccine.2010.05.033","article-title":"The RTS,S malaria vaccine","volume":"28","author":"Casares","year":"2010","journal-title":"Vaccine"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e00479-17","DOI":"10.1128\/IAI.00479-17","article-title":"Controlled Human Malaria Infection: Applications, advances, and challenges","volume":"86","author":"Stanisic","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/iai.61.2.729-733.1993","article-title":"Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: Changes with time and lack of correlation with protection","volume":"61","author":"Losonsky","year":"1993","journal-title":"Infect. Immuninty"},{"key":"ref_125","first-page":"3","article-title":"The utility of human challenge studies in vaccine development: Lessons learned from cholera","volume":"2011","author":"Shirley","year":"2011","journal-title":"Vaccine"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","article-title":"Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination","volume":"67","author":"Tacket","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","article-title":"Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR","volume":"166","author":"Tacket","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1016\/j.vaccine.2016.10.034","article-title":"Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency","volume":"37","author":"Vannice","year":"2019","journal-title":"Vaccine"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/3\/294\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:27:24Z","timestamp":1760135244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/3\/294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":129,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["pathogens11030294"],"URL":"https:\/\/doi.org\/10.3390\/pathogens11030294","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]}}}